Comparison

Y-27632 European Partner

Item no. TMO-T1870-25mg
Manufacturer TargetMol
CASRN 146986-50-7
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Isler D, et al. Pharmacol Rep. 2014, 66(1), 114-120.
Smiles C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc1ccncc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias ROCK inhibitor
Shipping Condition Cool pack
Available
Manufacturer - Targets
ROCK|||Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
247.34
Description
Y-27632 is an orally potent, ATP-competitive inhibitor of ROCK-I and ROCK-II. Y-27632 also inhibits isolation-induced apoptosis in mouse prostate stem or progenitor cells.
Pathways
Stem Cells|||Cell Cycle/Checkpoint|||Cytoskeletal Signaling|||Apoptosis
Bioactivity
Y-27632 is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay, exhibits >200-fold selectivity over Others kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK.
Receptor
ROCK1; ROCK2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close